Support First Things by turning your adblocker off or by making a  donation. Thanks!

A study reported on by The Scientist.Com claims that there has been no improvement in the efficiency of animal cloning since the birth of Dolly ten years ago. (Only 1-5% of attempts result in live births.) But the problem is a mystery since cloned embryos and fertilized embryos “look alike.”

Of acute interest, this problem of unknown cause, may make therapeutic cloning treatments dangerous. From the story: “These findings don’t bode well for those hoping to see stem cell therapy a reality anytime soon either, according to Wolf Reik, at the Babraham Institute in Cambridge, U.K. “Even if cloned [animal] embryos are born, many are not normal and die prematurely; these late effects are not caused by early deficits in gene expression, and that’s what this study shows,” said Reik. Consequently, stem cells used therapeutically may appear perfectly normal initially, with problems arising only later, he cautioned.”

None of this is a problem with adult/umbilical cord blood stem cells. When this truly penetrates the public’s consciousness, the debate will be won.

00 Days
00 Hours
00 Minutes
00 Seconds
Dear Reader,

Time is short, so I’ll be direct: FIRST THINGS needs you. And we need you by December 31 at 11:59 p.m., when the clock will strike zero. Give now at supportfirstthings.com.

First Things does not hesitate to call out what is bad. Today, there is much to call out. Yet our editors, authors, and readers like you share a greater purpose. And we are guided by a deeper, more enduring hope.

Your gift of $50, $100, or even $250 or more will bring this message of hope to many more people in the new year.

Make your gift now at supportfirstthings.com.

First Things needs you. I’m confident you’ll answer the call.

Make My Gift

Comments are visible to subscribers only. Log in or subscribe to join the conversation.

Tags

Loading...

Filter First Thoughts Posts

Related Articles